Erschienen in:
01.10.2006 | Original Article
Sarcomatoid carcinomas of the lung—are these histogenetically heterogeneous tumors?
verfasst von:
Markus Blaukovitsch, Iris Halbwedl, Hannelore Kothmaier, Margit Gogg-Kammerer, Helmut H. Popper
Erschienen in:
Virchows Archiv
|
Ausgabe 4/2006
Einloggen, um Zugang zu erhalten
Abstract
Sarcomatoid carcinomas (SC) of the lung are a heterogeneous group of nonsmall cell lung carcinomas (NSCLC) containing a sarcoma or sarcoma-like component. SC may represent an epithelial neoplasm undergoing divergent tissue differentiation originating from a single clone. Epithelial–mesenchymal transition (EMT) best describes the origin of the spindle and giant cells. We aimed to define chromosomal aberrations within the subgroups of SC and if EMT does play a role in SC. Twenty-two SC were investigated by chromosomal comparative genomic hybridization (CGH). Immunohistochemical staining was performed with antibodies for E-cadherin, Vimentin, c-Fos, c-Jun, Snail, TGFβ1, Notch1, β-catenin, Glycogen synthase kinase 3β (GSK3β), and Fascin. Gains occurred more frequently than losses (70.5 vs 29.5%). The shortest regions of overlap were gains on chromosomes 8q and 7 followed by 1q, 3q, and 19, supporting the common origin of the different subtypes of SC. The immunohistochemical staining suggests that the sarcomatoid components of SC might have undergone EMT, not triggered by the signaling pathways Notch1, Snail, and TGFβ1, but probably initiated by an upregulation of c-Jun and a consecutive overexpression of Vimentin and Fascin. The Wnt-pathway was not deregulated because combined membrane and cytoplasmic reactivity for β-catenin and GSK3β was observed.